Treatment of exacerbations of fibrotic idiopathic interstitial pneumonias with cyclophosphamide and corticosteroids Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010
Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia Source: Eur Respir J 2015; 45: 1624-1631 Year: 2015
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005
Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Source: Eur Respir J 2015; 45: 463-472 Year: 2015
Pulmonary function in HIV-infected brazilian children and adolescents with chronic interstitial pneumonitis Source: Eur Respir J 2005; 26: Suppl. 49, 166s Year: 2005
Treatment results using low doses of prednisolone, cyclophosphamide and extracorporeal processing of lymphocytes with prednisolone in patients with idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2003; 22: Suppl. 45, 197s Year: 2003
Low-dose corticosteroids during severe community-acquired pneumonia: end of the story Source: Eur Respir J 2015; 45: 305-307 Year: 2015
Systemic corticosteroid for treating severe community-acquired pneumonia Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019 Year: 2020
Azithromycin therapy in children with postinfectious bronchiolitis obliterans Source: International Congress 2016 – Paediatric respiratory infection Year: 2016
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018
Pneumocystis jiroveci Pneumonia prophylaxis in patients treated with mycophenolate mofetil for interstitial lung disease Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021
Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF) Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017 Year: 2018
Diagnosis and therapy of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) in Germany Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011
Acute bronchiolitis in hospitalised patients: inappropriate use of corticosteroids Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004